Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Atomoxetine in comorbid ADHD/PTSD: A randomized, placebo controlled, pilot, and feasibility study.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Atomoxetine in comorbid ADHD/PTSD: A randomized, placebo controlled, pilot, and feasibility study.
Atomoxetine in comorbid ADHD/PTSD: A randomized, placebo controlled, pilot, and feasibility study. Depress Anxiety. 2022 04; 39(4):286-295.
View in:
PubMed
subject areas
Adrenergic Uptake Inhibitors
Adult
Atomoxetine Hydrochloride
Attention Deficit Disorder with Hyperactivity
Cross-Over Studies
Double-Blind Method
Feasibility Studies
Humans
Propylamines
Quality of Life
Stress Disorders, Post-Traumatic
Treatment Outcome
authors with profiles
Mark B Hamner
Ursula Myers
Zachary D. Zuschlag